A detailed history of Gsg Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Gsg Advisors LLC holds 671 shares of AMGN stock, worth $197,629. This represents 0.07% of its overall portfolio holdings.

Number of Shares
671
Holding current value
$197,629
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$309.38 - $337.38 $207,593 - $226,381
671 New
671 $215 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gsg Advisors LLC Portfolio

Follow Gsg Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsg Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gsg Advisors LLC with notifications on news.